| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA5271603
Max Phase: Preclinical
Molecular Formula: C26H41N5O3
Molecular Weight: 471.65
Associated Items:
Representations
Canonical SMILES: CCCC[C@@H](CO)Nc1nc(N)nc(C)c1Cc1ccc(CC(=O)OCCCCN(C)C)cc1
Standard InChI: InChI=1S/C26H41N5O3/c1-5-6-9-22(18-32)29-25-23(19(2)28-26(27)30-25)16-20-10-12-21(13-11-20)17-24(33)34-15-8-7-14-31(3)4/h10-13,22,32H,5-9,14-18H2,1-4H3,(H3,27,28,29,30)/t22-/m0/s1
Standard InChI Key: LKMYDUPUYAWYEG-QFIPXVFZSA-N
Associated Targets(Human)
Toll-like receptor 7 2626 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 471.65 | Molecular Weight (Monoisotopic): 471.3209 | AlogP: 3.35 | #Rotatable Bonds: 15 |
| Polar Surface Area: 113.60 | Molecular Species: BASE | HBA: 8 | HBD: 3 |
| #RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: 9.79 | CX LogP: 3.71 | CX LogD: 0.87 |
| Aromatic Rings: 2 | Heavy Atoms: 34 | QED Weighted: 0.27 | Np Likeness Score: -0.33 |
References
| 1. Kaushik D, Kaur A, Petrovsky N, Salunke DB.. (2021) Structural evolution of toll-like receptor 7/8 agonists from imidazoquinolines to imidazoles., 12 (7.0): [PMID:34355178] [10.1039/D1MD00031D] |
Source
Source(1):